Maximum Entertainment (MAXENT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
27 May, 2026Executive summary
Revenue for Q1 2026 was €10.7M, down 29% year-over-year due to liquidity constraints impacting business opportunities.
Gross margin improved to 30% from 24% year-over-year, reflecting a shift to higher-margin sales and cost control.
Adjusted EBITDA was -€0.07M, a significant improvement from -€0.21M in Q1 2025.
Net loss for the quarter was €-1.8M, with EPS at €-0.04, compared to €-0.16 in Q1 2025.
The company remains dependent on additional financing to continue operations.
Financial highlights
Operating cash flow before working capital changes was -€0.6M, improved from -€1.9M year-over-year.
Operating cash flow after working capital changes was -€1.5M, down from €0.5M in Q1 2025 due to unfavorable working capital movements.
Cash and cash equivalents at quarter-end were €1.0M, down from €2.6M a year earlier.
Total loans increased to €50.6M from €42.8M, with net debt rising to €59.8M from €49.7M.
No new impairments of games were recorded in the quarter.
Outlook and guidance
The company is actively negotiating with lenders and financial partners to resolve liquidity and covenant breaches.
Ongoing uncertainty regarding the outcome of financing discussions and the ability to secure new funding.
The board has prepared a control balance sheet confirming equity below half of registered share capital; an EGM decided to continue operations.
Latest events from Maximum Entertainment
- Sharp revenue decline, heavy impairments, and restructuring amid severe liquidity risk.MAXENT
Q4 202531 Mar 2026 - Gross margin rose to 34% and adjusted EBITDA increased 15% YTD, with H2 set for major launches.MAXENT
Q2 20243 Feb 2026 - Net sales fell 26% to €25.5M amid restructuring, with legal and financing risks ongoing.MAXENT
Q4 20243 Feb 2026 - Sales and margins fell, but adjusted EBITDA improved; urgent financing and legal risks persist.MAXENT
Q3 20255 Nov 2025 - Sales and margins fell sharply, with liquidity and legal risks dominating the outlook.MAXENT
Q2 202513 Aug 2025 - Q3 2024 marked by lower sales, major impairments, and urgent financial restructuring.MAXENT
Q3 202413 Jun 2025 - Sales fell sharply and legal, financial risks persist despite cost cuts and new releases ahead.MAXENT
Q1 20256 Jun 2025